We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current BCTX market cap is 204.86M. The company's latest EPS is USD -0.1303 and P/E is -81.35.
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.5M | -9.85M | -9.27M | -5.88M | -5.22M |
| Net Income | 6M | -11.3M | 1.72M | -1.22M | -5.8M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.95M | -5.55M | -15.29M | -23.27M | -33.44M |
| Net Income | -4.03M | -428k | -26.84M | -20.3M | -4.79M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.62M | 12.23M | 6.2M | 5.87M | 10.41M |
| Total Liabilities | 16.1M | 20.55M | 12.44M | 8.56M | 6.7M |
| Total Equity | 2.52M | -8.32M | -6.23M | -2.69M | 3.71M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 522k | 58.04M | 42.58M | 27.16M | 5.87M |
| Total Liabilities | 4.12M | 782k | 32.25M | 30.94M | 8.56M |
| Total Equity | -3.6M | 57.26M | 10.33M | -3.78M | -2.69M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.61M | -15.01M | -20.09M | -24.13M | -6.96M |
| Investing | N/A | N/A | -225k | -682k | -75k |
| Financing | N/A | N/A | N/A | 4.42M | 11.96M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.27M | -7.75M | -12.48M | -23.75M | -24.13M |
| Investing | N/A | N/A | N/A | N/A | -682k |
| Financing | 1.17M | 64.99M | -3.74M | 3.95M | 4.42M |
| Market Cap | 204.86M |
| Price to Earnings Ratio | -81.35 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 452.99 |
| Price to Book Ratio | -145.2 |
| Dividend Yield | - |
| Shares Outstanding | 36.78M |
| Average Volume (1 week) | 306.02k |
| Average Volume (1 Month) | 818.17k |
| 52 Week Change | -91.42% |
| 52 Week High | 65.55 |
| 52 Week Low | 5.1164 |
| Spread (Intraday) | 0.49 (8.18%) |
| Company Name | BriaCell Therapeutics Corporation |
| Address |
suite 300 - 235 west 15th street vancouver, british columbia V7T 2X1 |
| Website | https://www.briacell.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
